The Spanish node of EATRIS is under the umbrella and coordination of the National Institute of Health Carlos III (ISCIII), as mandated official representative of Spain in EATRIS, and the Vall d’Hebron Institute of Research Institute (VHIR), Barcelona, as scientific leadership.
Spain participates with 15 translational accredited health research institutes whose added value is the creation of knowledge in the field of health research. This knowledge stems from within the most prominent Spanish hospitals which have access to first-hand clinical expertise and constitute the perfect environment for the translation of biomedical knowledge to the clinical practice and therefore to the patient (and vice-versa).
Some of the specific aims of Spain in EATRIS are to achieve a greater, better and stronger role of the Spanish biomedical research in the European Research Area, deepening the alignment of the Spanish Strategy for Science, Technology and Innovation 2013-2020 in Biomedicine and Health Sciences to the H2020 Programme of the European Union and to promote the efficient use of resources and interaction of centers from the Spanish National Health System with excellent research groups from other performing institutions and with industry.
Maria Laura García Bermejo
Co-chair Biomarker product platform; National Director of EATRIS Spain
BiomarkersEATRIS Spain participates in all the product platforms of the European Infrastructure, highlighting that Miguel Chillon from VHIR is Co-Chair of the Advanced Therapy Medicinal Products and Biologicals Product Platform, and Maria Laura Garcia Bermejo from IRYCIS is Co-Chair of the Biomarkers Product Platform.
